Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 86 results found. Search for [ novartis ceo ]

Results 1 to 21 of 86
BusinessToday.In
December 21, 2020
Tech spend is expected to increase to $2.9 trillion by 2021. We are looking at a seismic shift in the scaling of digitization at a pace never seen before, said Rakesh Rathi


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


Joe C Mathew
September 30, 2020
They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


PB Jayakumar
New Delhi, May 22, 2020
Though the government's SAUBHAGYA scheme claims to have provided connections to 100 per cent households, that is not sufficient. Under this scheme, the beneficiary households were provided only one LED light and one power plug, says Shailendra Roy


PTI
May 19, 2020
UN Secretary-General Antonio Guterres welcomed the ambitious, science-based actions from leading companies who are demonstrating to policy-makers that green growth remains the best growth strategy


Reuters
May 16, 2020
World's No.2 cigarette company said once it gets approval from the U.S. Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans


Reuters
May 15, 2020
Experts have said no vaccine is expected to be ready for use until at least 2021, as they must be widely tested in humans before being administered to hundreds of millions, if not billions, of people to prevent infection


Joe C Mathew | PB Jayakumar
March 4, 2020
'Right now, the focus is  about 80% innovative medicines and 20 per cent generics. We have 15 launches coming up in innovative medicines,' Novartis International CEO said


Joe C Mathew and PB Jayakumar
March 3, 2020
Novartis has completed strategic transactions worth over $70 billion since he took charge as CEO in 2018. In an exclusive interview with Business Today's Joe C. Mathew and P.B. Jayakumar, the second generation Indian American speaks about his vision for Novartis, new launches in India and the growing role of its Hyderabad centre


E Kumar Sharma
February 19, 2020
The Hyderabad centre is the Novartis' fourth digital hub. The three others are in San Francisco (US), Paris (France) and London (UK)


Mukesh Adhikary | Mohsin Shaikh
New Delhi, February 17, 2020
Chinese economy has seen a sudden shock with the outbreak of coronavirus in one of the country's top industrial hubs Wuhan. Many challenges lie ahead for the Asian giant as it continues to fight the epidemic. This BusinessToday.In infographic looks into the ongoing economic crisis in China due to coronavirus and its global impact


BusinessToday.In
New Delhi, February 17, 2020
The central government has constituted a Task Force on active pharmaceutical ingredients (APIs) to formulate a road map for the enhanced production of generic drugs in India


Joe C Mathew and PB Jayakumar
New Delhi, February 17, 2020
In an interview with Business Today, Narasimhan said expanding our knowledge base about such disease outbreak is important in order to take effective actions to address them


BusinessToday.In
December 17, 2019
Share Market Update: Sensex rose to its lifetime high of 41,401 in Tuesday's trade, NSE Nifty cliamed a all-time high of 12,182 today


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PTI
September 10, 2019



PTI
May 25, 2019



BusinessToday.In
April 13, 2019
The list by Ministry of Corporate Affairs shows major investment banks, tech companies, pharmaceutical firms and airlines afffected by the IL&FS toxic bonds


PAGES 1 OF 5  12345